CMS(00867) repurchased 507,000 shares at a cost of 5.5799 million Hong Kong dollars on June 1st.
Kangzhe Pharmaceutical (00867) announced that it will spend 5.5799 million Hong Kong dollars to repurchase 507,000 shares on June 1, 2026.
CMS (00867) announced to repurchase 507,000 shares at the cost of HKD 5.5799 million on June 1, 2026.
Related Articles
XIAO NOODLES (02408) spent HK$1.4016 million to repurchase 33,650 shares on June 1st.
Innovative Medical Management (002173.SZ) plans to repurchase company shares worth 50 million to 100 million yuan.
Sichuan Biokin Pharmaceutical (688506.SH) plans to repurchase shares worth 100 million to 200 million yuan.
XIAO NOODLES (02408) spent HK$1.4016 million to repurchase 33,650 shares on June 1st.
Innovative Medical Management (002173.SZ) plans to repurchase company shares worth 50 million to 100 million yuan.
Sichuan Biokin Pharmaceutical (688506.SH) plans to repurchase shares worth 100 million to 200 million yuan.
